Peder Jensen, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 10,000 shares at $3.56 ($36K) on 2011-05-12, disclosed to the SEC on 2011-05-16.
Open-market purchase of $36k BCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BCRX | BUY | 2012-12-17 | $30K | — | Filing → |
| BCRX | BUY | 2012-06-05 | $64K | — | Filing → |
| BCRX | BUY | 2011-11-18 | $28K | — | Filing → |